Literature DB >> 7168921

Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL).

H H Goebel, H Braak, D Seidel, R Doshi, C D Marsden, F Gullotta.   

Abstract

This report concerns morphologic findings in two middle-aged women, who died of sporadic adult neuronal ceroid-lipofuscinosis (NCL) and whose brains were studied histologically, by electron microscopy and by pigmentoarchitectonic techniques. In addition, the brain of a 35-year-old woman, who died of familial protracted juvenile NCL, was also investigated using pigmentoarchitectonic methods. Clinical, light and electron microscopic findings were compatible with the above-mentioned diagnosis. Pigmentoarchitectural analysis of homotypical isocortex in these three brains revealed (1) loss of pigment-laden stellate cells in layer II, (2) axonal enlargements of layer IIIab-pyramidal cells, and (3) considerable cell loss in layer Va. The changes were more pronounced in the brain affected by protracted juvenile NCL than in the two brains affected by adult NCL. The study emphasizes the value of the pigmentoarchitectonic technique, both in diagnostic neuropathology and in ascertaining patients afflicted with adult NCL. The ultrastructure of the lipopigments showed a motley spectrum of membrane formation such as curvilinear, fingerprint, or straight membranes and was less granular than regular senile lipofuscin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7168921

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  10 in total

1.  The adult and a new late adult forms of neuronal ceroid lipofuscinosis.

Authors:  J Constantinidis; K E Wisniewski; T M Wisniewski
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Lectin histochemistry in brains with juvenile form of neuronal ceroid-lipofuscinosis (Batten disease).

Authors:  K E Wisniewski; D Maslinska
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  The association of infantile osteopetrosis and neuronal storage disease in two brothers.

Authors:  V Jagadha; W C Halliday; L E Becker; D Hinton
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 4.  Ceroid, lipofuscin and the ceroid-lipofuscinoses (Batten disease).

Authors:  R D Jolly; R R Dalefield; D N Palmer
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Topographic heterogeneity of amyloid B-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein.

Authors:  K E Wisniewski; D Maslinska; T Kitaguchi; K S Kim; H H Goebel; M Haltia
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.

Authors:  Mallorie Poët; Uwe Kornak; Michaela Schweizer; Anselm A Zdebik; Olaf Scheel; Sabine Hoelter; Wolfgang Wurst; Anja Schmitt; Jens C Fuhrmann; Rosa Planells-Cases; Sara E Mole; Christian A Hübner; Thomas J Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-01       Impact factor: 11.205

Review 7.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

8.  Accumulation of glial fibrillary acidic protein and histone H4 in brain storage bodies of Tibetan terriers with hereditary neuronal ceroid lipofuscinosis.

Authors:  M L Katz; D N Sanders; B P Mooney; Gary S Johnson
Journal:  J Inherit Metab Dis       Date:  2007-11-15       Impact factor: 4.982

Review 9.  Protracted juvenile neuronal ceroid-lipofuscinosis.

Authors:  H H Goebel
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

10.  Lysosomal storage of subunit c of mitochondrial ATP synthase in Batten's disease (ceroid-lipofuscinosis).

Authors:  N A Hall; B D Lake; N N Dewji; A D Patrick
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.